Paper34849481
Four decades in the making: Collagen III and mechanisms of vascular Ehlers Danlos Syndrome.
Omar R and 2 others. Matrix Biol Plus, 2021. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Four decades in the making: Collagen III and mechanisms of vascular Ehlers Danlos Syndrome. Papers, record 34849481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34849481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Four decades in the making: Collagen III and mechanisms of vascular Ehlers Danlos Syndrome.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/R005567/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25653287 | Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease. | Neurology | 2015 | https://conductscience.org/library/papers/25653287 | PubMed |
| 2 | 27060106 | Collagen structure: new tricks from a very old dog. | Biochem J | 2016 | https://conductscience.org/library/papers/27060106 | PubMed |
| 3 | 6507506 | Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen. | Am J Med Genet | 1984 | https://conductscience.org/library/papers/6507506 | PubMed |
| 4 | 9036918 | Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis. | J Invest Dermatol | 1997 | https://conductscience.org/library/papers/9036918 | PubMed |
| 5 | 33823651 | Quality Control of Procollagen in Cells. | Annu Rev Biochem | 2021 | https://conductscience.org/library/papers/33823651 | PubMed |
| 6 | 10706896 | Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. | N Engl J Med | 2000 | https://conductscience.org/library/papers/10706896 | PubMed |
| 7 | 19455184 | Homozygosity for a null allele of COL3A1 results in recessive Ehlers-Danlos syndrome. | Eur J Hum Genet | 2009 | https://conductscience.org/library/papers/19455184 | PubMed |
| 8 | 29346445 | Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome. | PLoS One | 2018 | https://conductscience.org/library/papers/29346445 | PubMed |
| 9 | 9050868 | Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9050868 | PubMed |
| 10 | 1055406 | Patients with Ehlers-Danlos syndrome type IV lack type III collagen. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1055406 | PubMed |
| 11 | 16081813 | Demonstration of autoimmunity in the tight skin-2 mouse: a model for scleroderma. | J Immunol | 2005 | https://conductscience.org/library/papers/16081813 | PubMed |
| 12 | 26839400 | ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice. | Dis Model Mech | 2016 | https://conductscience.org/library/papers/26839400 | PubMed |
| 13 | 25330296 | The Tsk2/+ mouse fibrotic phenotype is due to a gain-of-function mutation in the PIIINP segment of the Col3a1 gene. | J Invest Dermatol | 2015 | https://conductscience.org/library/papers/25330296 | PubMed |
| 14 | 31409039 | Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes. | Genes (Basel) | 2019 | https://conductscience.org/library/papers/31409039 | PubMed |
| 15 | 29543232 | Targeted genetic analysis in a large cohort of familial and sporadic cases of aneurysm or dissection of the thoracic aorta. | Genet Med | 2018 | https://conductscience.org/library/papers/29543232 | PubMed |
| 16 | 22038052 | Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts. | FASEB J | 2012 | https://conductscience.org/library/papers/22038052 | PubMed |
| 17 | 30541925 | Roles of the endoplasmic reticulum-resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease. | J Biol Chem | 2019 | https://conductscience.org/library/papers/30541925 | PubMed |
| 18 | 24664438 | Variants of COL3A1 are associated with the risk of stroke recurrence and prognosis in the Chinese population: a prospective study. | J Mol Neurosci | 2014 | https://conductscience.org/library/papers/24664438 | PubMed |
| 19 | 437782 | Clinical and ultrastructural heterogeneity of type IV Ehlers-Danlos syndrome. | Hum Genet | 1979 | https://conductscience.org/library/papers/437782 | PubMed |
| 20 | 34390685 | Sequence-dependent mechanics of collagen reflect its structural and functional organization. | Biophys J | 2021 | https://conductscience.org/library/papers/34390685 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42681153 | Trypsin Digestion to Assess Triple Helix Stability in Collagens as Measure of Collagen Folding. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42681153 | PubMed |
| 42608597 | Cellular crosstalk between endothelial and vascular smooth muscle cells via the BACH1/COL3A1 axis promotes vascular calcification in chronic kidney disease. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42608597 | PubMed |
| 42465249 | Behavioral and Functional Profiling of Acomys cahirinus Fibroblasts Reveals Enhanced Matrix Remodeling Capacity. | bioRxiv | 2026 | https://conductscience.org/library/papers/42465249 | PubMed |
| 42318957 | Genetic and molecular mechanisms of hereditary thoracic aortic aneurysm and dissection (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42318957 | PubMed |
| 42170682 | Prolyl 3-hydroxylase 1 (P3H1) deficient osteogenesis imperfecta with vascular malformations: a rare disorder with atypical features. | JBMR Plus | 2026 | https://conductscience.org/library/papers/42170682 | PubMed |
| 40790091 | Gene editing for collagen disorders: current advances and future perspectives. | Gene Ther | 2025 | https://conductscience.org/library/papers/40790091 | PubMed |
| 40542421 | Prevalence of vascular complications in Ehlers-Danlos syndrome: a systematic review and meta-analysis. | Orphanet J Rare Dis | 2025 | https://conductscience.org/library/papers/40542421 | PubMed |
| 40280907 | The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos Syndrome. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40280907 | PubMed |
| 40219677 | Identification and Structural Characterization of a Novel COL3A1 Gene Duplication in a Family With Vascular Ehlers-Danlos Syndrome. | Mol Genet Genomic Med | 2025 | https://conductscience.org/library/papers/40219677 | PubMed |
| 39767655 | Integrative Multi-Omics Approach in Vascular Ehlers-Danlos Syndrome: Further Insights into the Disease Mechanisms by Proteomic Analysis of Patient Dermal Fibroblasts. | Biomedicines | 2024 | https://conductscience.org/library/papers/39767655 | PubMed |
| 39730916 | Vascular Ehlers-Danlos syndrome in children: evaluating the importance of diagnosis and follow-up during childhood. | Eur J Hum Genet | 2025 | https://conductscience.org/library/papers/39730916 | PubMed |
| 38183136 | Dysregulation of extracellular matrix and Lysyl Oxidase in Ehlers-Danlos syndrome type IV skin fibroblasts. | Orphanet J Rare Dis | 2024 | https://conductscience.org/library/papers/38183136 | PubMed |
| 38173017 | Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's disease. | Transl Neurodegener | 2024 | https://conductscience.org/library/papers/38173017 | PubMed |
| 37894834 | Local Net Charge State of Collagen Triple Helix Is a Determinant of FKBP22 Binding to Collagen III. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37894834 | PubMed |
| 37623497 | Bowel Perforation in Vascular Ehlers-Danlos Syndrome: Case Report and Comprehensive Review. | J Pers Med | 2023 | https://conductscience.org/library/papers/37623497 | PubMed |
| 37404745 | Case report: Complex arterial findings in vascular ehlers-danlos syndrome with a novel COL3A1 variant and death at young age. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/37404745 | PubMed |
| 36925590 | Adjustment to disease and quality of life in people with vascular Ehlers-Danlos and Loeys-Dietz syndromes: A mixed-method study. | Front Psychol | 2023 | https://conductscience.org/library/papers/36925590 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34849481
GET https://conductscience.org/api/papers/v1/34849481/references?page=2